Dow Up 0.11% Nasdaq Up 0.50%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.36 Down 0.03(1.26%) Aug 29, 4:00PM EDT
Prev Close:2.39
Open:2.37
Bid:2.25 x 1000
Ask:2.35 x 1000
1y Target Est:5.86
Beta:1.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.30 - 2.39
52wk Range:1.66 - 7.77
Volume:1,012,913
Avg Vol (3m):3,197,710
Market Cap:278.96M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEDown 1.26%278.96M
CELGUp 0.34%75.97B
VSTMDown 1.36%225.08M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback